Evidence map›Paper›PMID 30361511›Full record

ArticleNature medicine2018

Publisher Correction: Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma.

Rodabe N Amaria, Sangeetha M Reddy, Hussein A Tawbi, Michael A Davies, Merrick I Ross, Isabella C Glitza, Janice N Cormier, Carol Lewis, Wen-Jen Hwu, Ehab Hanna and 35 more

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Nature medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. Review
  3. Review
  4. Article
  5. Immunotherapy for Neuro-oncology.Advances in experimental medicine and biology · 2021
    Review
  6. Article
  7. Neoadjuvant therapy of locally/regionally advanced melanoma.Therapeutic advances in medical oncology · 2019
    Review
  8. New window of opportunity with ICIs in melanoma.Nature reviews. Clinical oncology · 2018
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

45 authors.

Rodabe N AmariaDepartment of Melanoma Medical Oncology, MD Anderson Cancer Center, Houston, TX, USA.ORCID http://orcid.org/0000-0001-6876-278X
Sangeetha M ReddyDepartment of Breast Medical Oncology, MD Anderson Cancer Center, Houston, TX, USA.
Hussein A TawbiDepartment of Melanoma Medical Oncology, MD Anderson Cancer Center, Houston, TX, USA.
Michael A DaviesDepartment of Melanoma Medical Oncology, MD Anderson Cancer Center, Houston, TX, USA.ORCID http://orcid.org/0000-0002-0977-0912
Merrick I RossDepartment of Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA.
Isabella C GlitzaDepartment of Melanoma Medical Oncology, MD Anderson Cancer Center, Houston, TX, USA.
Janice N CormierDepartment of Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA.
Carol LewisDepartment of Head and Neck Surgery, MD Anderson Cancer Center, Houston, TX, USA.
Wen-Jen HwuDepartment of Melanoma Medical Oncology, MD Anderson Cancer Center, Houston, TX, USA.
Ehab HannaDepartment of Head and Neck Surgery, MD Anderson Cancer Center, Houston, TX, USA.
Adi DiabDepartment of Melanoma Medical Oncology, MD Anderson Cancer Center, Houston, TX, USA.
Michael K WongDepartment of Melanoma Medical Oncology, MD Anderson Cancer Center, Houston, TX, USA.
Richard RoyalDepartment of Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA.
Neil GrossDepartment of Head and Neck Surgery, MD Anderson Cancer Center, Houston, TX, USA.ORCID http://orcid.org/0000-0002-9427-0743
Randal WeberDepartment of Head and Neck Surgery, MD Anderson Cancer Center, Houston, TX, USA.
Stephen Y LaiDepartment of Head and Neck Surgery, MD Anderson Cancer Center, Houston, TX, USA.
Richard EhlersDepartment of Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA.
Jorge BlandoDepartment of Immunology, MD Anderson Cancer Center, Houston, TX, USA.
Denái R MiltonDepartment of Biostatistics, MD Anderson Cancer Center, Houston, TX, USA.
Scott WoodmanDepartment of Melanoma Medical Oncology, MD Anderson Cancer Center, Houston, TX, USA.
Robin KageyamaParker Institute for Cancer Immunotherapy, San Francisco, CA, USA.
Daniel K WellsParker Institute for Cancer Immunotherapy, San Francisco, CA, USA.
Patrick HwuDepartment of Melanoma Medical Oncology, MD Anderson Cancer Center, Houston, TX, USA.
Sapna P PatelDepartment of Melanoma Medical Oncology, MD Anderson Cancer Center, Houston, TX, USA.
Anthony LucciDepartment of Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA.
Amy HesselDepartment of Head and Neck Surgery, MD Anderson Cancer Center, Houston, TX, USA.
Jeffrey E LeeDepartment of Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA.
Jeffrey GershenwaldDepartment of Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA.
Lauren SimpsonDepartment of Melanoma Medical Oncology, MD Anderson Cancer Center, Houston, TX, USA.
Elizabeth M BurtonDepartment of Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA.
Liberty PosadaDepartment of Melanoma Medical Oncology, MD Anderson Cancer Center, Houston, TX, USA.
Lauren HayduDepartment of Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA.
Linghua WangDepartment of Genomic Medicine, MD Anderson Cancer Center, Houston, TX, USA.ORCID http://orcid.org/0000-0001-9380-0266
Shaojun ZhangDepartment of Genomic Medicine, MD Anderson Cancer Center, Houston, TX, USA.
Alexander J LazarDepartment of Pathology, MD Anderson Cancer Center, Houston, TX, USA.ORCID http://orcid.org/0000-0002-6395-4499
Courtney W HudgensDepartment of Pathology, MD Anderson Cancer Center, Houston, TX, USA.ORCID http://orcid.org/0000-0001-8312-7485
Vancheswaran GopalakrishnanDepartment of Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA.
Alexandre ReubenDepartment of Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA.ORCID http://orcid.org/0000-0003-4510-0382
Miles C AndrewsDepartment of Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA.
Christine N SpencerDepartment of Genomic Medicine, MD Anderson Cancer Center, Houston, TX, USA.
Victor PrietoDepartment of Pathology, MD Anderson Cancer Center, Houston, TX, USA.
Padmanee SharmaDepartment of Immunology, MD Anderson Cancer Center, Houston, TX, USA.
James AllisonDepartment of Immunology, MD Anderson Cancer Center, Houston, TX, USA.
Michael T TetzlaffDepartment of Pathology, MD Anderson Cancer Center, Houston, TX, USA.
Jennifer A WargoDepartment of Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA. jwargo@mdanderson.org.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the version of this article originally published, there was an error in Fig. 1. In the neoadjuvant phase column, the n values for arms A and B were both reported to be 20. The n values for arms A and B were actually 12 and 11, respectively. Also, the URL underlying the accession code in the data availability section was incorrect. The URL was originally https://www.ebi.ac.uk/ega/studies/EGAS00001002698. It should have been https://www.ebi.ac.uk/ega/studies/EGAS00001003178. The errors have been corrected in the print, HTML and PDF versions of this article.

Identifiers

PMID30361511

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.